User profiles for Jérémie Riou
Jérémie RiouMaître de Conférence en Biostatistique, UMR INSERM 1066, CNRS 6021, Université d' … Verified email at univ-angers.fr Cited by 1208 |
High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled …
Background Vitamin D supplementation has been proposed as a treatment for Coronavirus
Disease 2019 (COVID-19) based on experimental data and data from small and …
Disease 2019 (COVID-19) based on experimental data and data from small and …
Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs
Background & Aims The aim of this study was to use a head-to-head nodule comparison to
compare the performance of extracellular contrast agent MRI (ECA-MRI) with that of …
compare the performance of extracellular contrast agent MRI (ECA-MRI) with that of …
Spontaneous nano-emulsification: Process optimization and modeling for the prediction of the nanoemulsion's size and polydispersity
The aim of the present study was to optimize the size and polydispersity of a lipid
nanoemulsion as a function of the oil (Labrafac ® WL1349), surfactant (Kolliphor ® HS 15) and …
nanoemulsion as a function of the oil (Labrafac ® WL1349), surfactant (Kolliphor ® HS 15) and …
Endometriosis lowers the cumulative live birth rates in IVF by decreasing the number of embryos but not their quality
Endometriosis and infertility are closely linked, but the underlying mechanisms are still
poorly understood. This study aimed to evaluate the impact of endometriosis on in vitro …
poorly understood. This study aimed to evaluate the impact of endometriosis on in vitro …
[HTML][HTML] Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: a cohort study
T Moumneh, J Riou, D Douillet, S Henni… - Journal of thrombosis …, 2020 - Elsevier
Background Because hospital‐acquired venous thromboembolism (VTE) represents a frequent
cause of preventable deaths in medical inpatients, identifying at‐risk patients requiring …
cause of preventable deaths in medical inpatients, identifying at‐risk patients requiring …
Targeted prophylactic anticoagulation based on the TRiP (cast) score in patients with lower limb immobilisation: a multicentre, stepped wedge, randomised …
…, L Soulat, N Marjanovic, T Moumneh, D Savary, J Riou… - The Lancet, 2024 - thelancet.com
Background Prophylactic anticoagulation in emergency department patients with lower limb
trauma requiring immobilisation is controversial. The Thrombosis Risk Prediction for …
trauma requiring immobilisation is controversial. The Thrombosis Risk Prediction for …
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events
…, Y Sánchez, E Dincuff, A Lucena, M Roux, J Riou… - Journal of …, 2022 - Elsevier
Background & Aims Previous studies on the prognostic significance of non-invasive liver
fibrosis tests in non-alcoholic fatty liver disease (NAFLD) lack direct comparison to liver biopsy. …
fibrosis tests in non-alcoholic fatty liver disease (NAFLD) lack direct comparison to liver biopsy. …
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation
D Luque Paz, R Jouanneau-Courville, J Riou… - Blood …, 2020 - ashpublications.org
Among myeloproliferative neoplasms, polycythemia vera (PV) and essential thrombocythemia
(ET) are the 2 entities associated with the most chronic disease course. Leukemic …
(ET) are the 2 entities associated with the most chronic disease course. Leukemic …
Regular use of VKA prior to COVID-19 associated with lower 7-day survival in hospitalized frail elderly COVID-19 patients: the GERIA-COVID cohort study
Background. Vitamin K concentrations are inversely associated with the clinical severity of
COVID-19. The objective of this cohort study was to determine whether the regular use of …
COVID-19. The objective of this cohort study was to determine whether the regular use of …
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study
D Luque Paz, J Riou, E Verger, B Cassinat… - Blood …, 2021 - ashpublications.org
We aimed to study the prognostic impact of the mutational landscape in primary and
secondary myelofibrosis. The study included 479 patients with myelofibrosis recruited from 24 …
secondary myelofibrosis. The study included 479 patients with myelofibrosis recruited from 24 …